Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$63.75 - $108.06 $324,232 - $549,593
5,086 New
5,086 $356,000
Q1 2021

May 13, 2021

SELL
$18.57 - $25.68 $576,394 - $797,081
-31,039 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$15.26 - $28.61 $1.06 Million - $1.99 Million
-69,706 Reduced 69.19%
31,039 $645,000
Q3 2020

Nov 09, 2020

SELL
$20.58 - $28.96 $93,350 - $131,362
-4,536 Reduced 4.31%
100,745 $2.18 Million
Q2 2020

Aug 12, 2020

SELL
$11.15 - $24.64 $499,207 - $1.1 Million
-44,772 Reduced 29.84%
105,281 $2.48 Million
Q1 2020

May 04, 2020

SELL
$8.75 - $16.3 $21,551 - $40,146
-2,463 Reduced 1.61%
150,053 $1.77 Million
Q4 2019

Feb 12, 2020

SELL
$7.95 - $11.84 $221,375 - $329,696
-27,846 Reduced 15.44%
152,516 $1.62 Million
Q3 2019

Nov 12, 2019

SELL
$10.82 - $14.25 $25,968 - $34,200
-2,400 Reduced 1.31%
180,362 $2.05 Million
Q2 2019

Aug 16, 2019

SELL
$7.95 - $11.25 $13,515 - $19,125
-1,700 Reduced 0.92%
182,762 $2.06 Million
Q1 2019

May 13, 2019

SELL
$5.95 - $10.19 $81,413 - $139,429
-13,683 Reduced 6.91%
184,462 $1.49 Million
Q4 2018

Feb 05, 2019

BUY
$5.91 - $9.29 $452,097 - $710,657
76,497 Added 62.88%
198,145 $1.25 Million
Q3 2018

Nov 07, 2018

SELL
$6.4 - $9.85 $21,772 - $33,509
-3,402 Reduced 2.72%
121,648 $1.2 Million
Q2 2018

Aug 10, 2018

BUY
$6.9 - $9.9 $283,424 - $406,652
41,076 Added 48.92%
125,050 $1.04 Million
Q1 2018

May 08, 2018

BUY
$7.2 - $10.05 $2,880 - $4,020
400 Added 0.48%
83,974 $604,000
Q4 2017

Feb 13, 2018

SELL
$7.25 - $15.65 $40,179 - $86,732
-5,542 Reduced 6.22%
83,574 $682,000
Q2 2017

Nov 20, 2017

BUY
N/A
89,116
89,116 $1.08 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.31B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.